Abstract:Objective To study the dynamics changes of cerebrospinal fluid (CSF) bacterial load within 48 h after infection in a rabbit meningitis model, and provide information for diagnosis,treatment and prognosis of this disease. Methods Taking New Zealand white rabbit as the study object, meningitis model was established via cerebellar cistern puncture with different concentrations of Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) to explore the relationship between the mortality of animals and the subarachnoid inoculation dosage. The dynamics study of CSF bacterial load was conducted with proper inoculation bacterial dosage. Forty-eight rabbits were separated into four groups (12 each group): E. coli meningitis model group, E. coli meningitis + ceftriaxone treated group, S. aureus meningitis model group and S. aureus meningitis + vancomycin treated group. At 0,12, 24, 36 and 48 h of inoculation, CSF and blood samples were obtained for CSF bacterial quantitative culture, CSF leukocyte count and peripheral blood leukocyte count. Finally, the relationships between the early mortality of animals, the efficacy of antibiotics, CSF leukocyte counts and the dynamics changes of CSF bacterial load were analyzed in the bacterial meningitis rabbit model.The CSF bacterial load and the white blood cell count curve were compared by analysis of covariance (ANOVA). Correlation test was done using correlate partial analysis. Results The relationship between subarachnoid inoculation dosage and the mortality of rabbits presented S-curve correlation.The bacterial load in subarachnoid space peaked in 12-24 h after infection and then gradually decreased. Effective antibiotic therapy could significantly speed up the decline of this process. There were significantly different between E. coli meningitis model group and E. coli meningitis+ceftriaxone treated group (F= 27. 10, P<0. 01), between S. aureus meningitis model group and S. aureus meningitis + vancomycin treated group (F=5. 97, P = 0. 016). There was a positive correlation between CSF bacterial load and CSF leukocyte count in E. coli and S. aureus meningitis model groups (r=0. 89, 0.84, respectively; P = 0.046, 0.049, respectively). Conclusions In the treatment of bacterial meningitis, effective and sufficient antibiotics should be used as soon as possible to control the CSF bacterial load and reduce the mortality. The CSF leukocyte count can be used as indicator of CSF bacterial load and guide the antibiotic treatment in clinical bacterial meningitis.

[Therapeutic Effect of Ceftazidime in a Rabbit Model of Peritonitis Caused by Escherichia Coli Producing CTX-M-14 Extended-Spectrum Beta-Lactamase].

The therapeutic effect of antibiotics on rabbit peritonitis caused by Escherichia Coli producing CTX-M-14 type ESBL

Establishing of the Animal Model of Bacterial Peritonitis Caused by Escherichia Coli in Rabbit

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae

Efficacy of ceftazidime/avibactam in various combinations for the treatment of experimental osteomyelitis in rabbits caused by OXA-48-/ESBL-producing Escherichia coli

Ceftolozane-Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance

Outcome of Cephalosporin Treatment of Bacteremia Due to CTX-M–type Extended-Spectrum Β-Lactamase–producing Escherichia Coli

Efficacy of Phage Therapy in Controlling Rabbit Colibacillosis and Changes in Cecal Microbiota

The early dynamics study of cerebrospinal fluid bacterial in a rabbit model of bacterial meningitis

Assessment the role of some Bacillus strains in improvement rex rabbits resistance against ETEC challenge

Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae

Abdominal Infection of Rabbit due to Drug-resistant Bacteria: Establishment of Animal Model

Pharmacodynamic Effect of Compound Qingre Granules on Acute Drug-resistance Bacterial Infection

An experimental model of chronic osteomyelitis caused by Escherichia coli treated with cefotaxime

Illumina Miseq Platform Analysis Caecum Bacterial Communities of Rex Rabbits Fed with Different Antibiotics

Treatment effects of the combination of cefuroxime and tazobactam against mouse septicemia infected by β-lactamases producing strains

Pathophysiologic Characterization of a Novel Rabbit Model of Biliary Tract Infection-Derived Sepsis.

Efficacy and Safety of Ceftazidime-Avibactam in the Treatment of Complicated Intra-Abdominal Infections (ciais) and Complicated Urinary Tract Infections (cutis): A Meta-Analysis of Randomized Controlled Trials

Closing the Gaps: Testing the Efficacy of Carbapenem and Cephalosporin Treatments of Late-Stage Anthrax in Rabbits

Comparison of the Inoculum Effect of in Vitro Antibacterial Activity of Imipenem/relebactam and Ceftazidime/avibactam Against ESBL-, KPC- and AmpC-producing Escherichia Coli and Klebsiella Pneumoniae

Ex Vivo Pharmacokinetic/pharmacodynamic Relationship of Valnemulin Against Clostridium Perfringens in Plasma, the Small Intestinal and Caecal Contents of Rabbits.